|
KR20200122261A
|
|
Natural killer cells having increased anti-cancer activity and immunotherapy uses thereof
|
|
KR20200028865A
|
|
Differentiation induction culture medium for pluripotent stem cells derived MSCs, method for producing MSCs and MSCs produced using the same
|
|
KR20190003438A
|
|
Method for inducing differentiation of human embryonic stem cells into mesodermal lineage cells
|
|
KR20190041594A
|
|
Therapeutic composition for skin regeneration and wound healing using CLASP2
|
|
KR20190037546A
|
|
Composition for treating wound containing epidermal stem cell conditioned medium and use thereof
|
|
KR20190003241A
|
|
Stem cell-derived epidermal progenitor cell conditioned medium and method for production thereof
|
|
KR101830062B1
|
|
Composition for anti-aging containing epidermal stem cell conditioned medium and use thereof
|
|
KR20180038236A
|
|
Method for preparing niosomes, niosomes prepared by the same, and use thereof
|
|
US2018325960A1
|
|
Enhanced postnatal adherent cell, and use for same
|
|
WO2017039251A1
|
|
Enhanced postnatal adherent cell, and use for same
|
|
CN108138137A
|
|
The adhesion stem cell in the umbilical cord source of enhancing, Its Preparation Method And Use
|
|
WO2017026838A1
|
|
Improved umbilical cord-derived adhesive stem cells, preparation method therefor, and use thereof
|
|
WO2016209021A1
|
|
Method for proliferating natural killer cells and composition for proliferating natural killer cells
|
|
KR20170000798A
|
|
Method and Composition for Proliferating of Natural Killer Cell
|
|
US2018112184A1
|
|
Postnatal adherent cells and preparation method therefor
|
|
WO2016190704A1
|
|
Improved postnatal adherent cells and preparation method therefor
|
|
KR20170040590A
|
|
Formulation for topical application contaning emodin
|
|
JP2017012010A
|
|
Method of growing natural killer cells and composition for growing natural killer cells
|
|
KR20160035920A
|
|
Method for inducing differentiation of human embryonic stem cells into mesodermal lineage cells
|
